Modulation of acetylcholine release from mouse cortex by protein kinase C: Dependence on stimulation intensity

Life Sciences

Volumn 67, Issue 1, 2000, Pages 31-38

  Iannazzo, Lydia ^a,b   Kotsonis, Peter ^a   Majewski, Henryk ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b RMIT UNIVERSITY   (Australia)

Author keywords

Acetylcholine; Mouse cortex; Protein kinase C

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; ACETYLCHOLINE; BISINDOLYLMALEIMIDE; CALPHOSTIN C; CHOLINE; NEOSTIGMINE; PHORBOL DIBUTYRATE; POLYMYXIN B; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR;

ACETYLCHOLINE BRAIN LEVEL; ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CONTROLLED STUDY; ELECTROSTIMULATION; ENZYME ACTIVITY; MALE; MOUSE; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN;

ACETYLCHOLINE; ANIMALS; CEREBRAL CORTEX; ELECTRIC STIMULATION; ENZYME INHIBITORS; MALE; MICE; NEOSTIGMINE; PHORBOL 12,13-DIBUTYRATE; POLYMYXIN B; PROTEIN KINASE C;

ANIMALIA;

EID: 0034717304     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00600-7     Document Type: Article

References (29)

1. S. Stabel and P. Parker, Pharmacol. Ther. 51 71-95 (1991).
2. Y. Nishizuka, Science 258 607-614 (1992).
3. H. Majewski and L. Iannazzo, Prog. Neurobiol. 55 463-475 (1998).
4. C. Tanaka, H. Fujiwara and Y. Fujii, FEBS Letters 195 129-134 (1986).
5. D.H. Versteeg and W.J. Florijn, Life Sciences 40 1237-1243 (1987).
6. L. Iannazzo, P. Kotsonis and H. Majewski, Br. J. Pharmacol. 127 1177-1189 (1999).
7. C. Allgaier, B. Daschmann, H.Y. Huang and G. Hertting, Br. J. Pharmacol. 93 525-534 (1988).
8. B. Daschmann, C. Allgaier, R. Nakov and G. Hertting, Arch. Int. Pharmacodyn. 296 232-245 (1988).
9. R.A. Nichols, J.W. Haycock, J.K.T. Wang and P. Greengard, J. Neurochem. 48 615-621 (1987).
10. X. Guitart, J. Marsal and C. Solsna, J. Neurochem. 55 468-472 (1990).
11. C. Tanaka, K. Taniyama and M. Kusunoki, FEBS Letters 175 165-169 (1984).
12. S. Hashimoto, H. Shuntoh, K. Taniyama and C. Tanaka, Jap. J. Pharmacol. 48 377-385 (1988).
13. C. Dietrich and H. Kilbinger, Neuropharmacol. 35 483-8 (1996).
14. C.G. Caratsch, S. Schumacher, F. Grassi and F. Eusebi, Naunyn-Schmied. Arch. Pharmacol. 337 9-12 (1988).
15. R.L. Murphy and M.E. Smith, Br. J. Pharmacol. 90 327-334 (1987).
16. C. Haimann, J. Meldolesi and B. Ceccarelli, Pflügers Arch. Eur. J. Physiol. 408 27-31 (1987).
17. J.J. Dawson, L. Iannazzo and H. Majewski, J. Autonom. Pharmacol. 16 79-85 (1996).
18. C. Allgaier, G. Hertting, H.Y. Huang, and R. Jackisch, Br. J. Pharmacol. 92 161-172 (1987).
19. S. Foucart, I.F. Musgrave and H. Majewski, Neuropeptides 15 179-185 (1990).
20. P. Kotsonis and H. Majewski, Br. J. Pharmacol. 119 115-125 (1996).
21. H. Majewski, P. Kotsonis, T.V. Murphy and M. Barrington, Br. J. Pharmacol. 121 1196-1202 (1997).
22. K. Starke, M. Göthert and H. Kilbinger, Physiol. Rev. 69 864-989 (1989).
23. G.E. Schroeder, P. Kotsonis, I.F. Musgrave and H. Majewski, Br. J. Pharmacol. 116 2757- 2763 (1995).
24. R.K. Talmaciu, I.S. Hoffmann and L.X. Cubeddu, J. Pharmacol. Exp. Ther. 251 1160-5 (1989).
25. J.C. Szerb and G.T. Somogyi, Nature 241 121-122 (1973).
26. P.D. Davis, C.H. Hill, J.S. Lawton, S.E. Wilkinson, S.A. Hurst, E. Keech and S.E. Turner, J. Med. Chem. 35 177-184 (1992).
27. G. Martiny-Baron, M.G. Kazanietz, H. Mischak, P.M. Blumberg, G. Kochs, H. Hug, D. Marme, and C. Schachtele, J. Biol. Chem. 268 9194-9197 (1993).
28. R.F. Bruns, F.D. Miller, R.L. Merriman, J.J. Howbert, W.F, Heath, E. Kobayashi, I. Takajashi, T. Tamaoki and H. Nakano, Biochem. Biophys. Res. Comm. 176 288-293 (1991).
29. D. Toullec, P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle et al., J. Biol. Chem. 266 15771-15781 (1991).